KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Nektar Therapeutics (NKTR) Inventory Average: 2011-2024

Historic Inventory Average for Nektar Therapeutics (NKTR) over the last 12 years, with Jun 2024 value amounting to $15.4 million.

  • Nektar Therapeutics' Inventory Average fell 24.98% to $15.4 million in Q2 2024 from the same period last year, while for Jun 2024 it was $15.4 million, marking a year-over-year decrease of 24.98%. This contributed to the annual value of $17.7 million for FY2023, which is 0.86% up from last year.
  • As of Q2 2024, Nektar Therapeutics' Inventory Average stood at $15.4 million, which was down 5.06% from $16.2 million recorded in Q1 2024.
  • Nektar Therapeutics' Inventory Average's 5-year high stood at $20.5 million during Q2 2023, with a 5-year trough of $12.7 million in Q3 2020.
  • Over the past 3 years, Nektar Therapeutics' median Inventory Average value was $17.0 million (recorded in 2022), while the average stood at $17.4 million.
  • In the last 5 years, Nektar Therapeutics' Inventory Average rose by 26.51% in 2023 and then decreased by 24.98% in 2024.
  • Quarterly analysis of 5 years shows Nektar Therapeutics' Inventory Average stood at $14.1 million in 2020, then grew by 10.46% to $15.6 million in 2021, then rose by 22.90% to $19.1 million in 2022, then declined by 18.37% to $15.6 million in 2023, then fell by 24.98% to $15.4 million in 2024.
  • Its Inventory Average was $15.4 million in Q2 2024, compared to $16.2 million in Q1 2024 and $15.6 million in Q4 2023.